NDC 17856-0600-04 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0600
- Requested NDC
- 17856-0600-04
- Package NDCs from labels
- 17856-0600-4, 17856-0600-1, 17856-0600-5, 17856-0600-2, 17856-0600-6, 17856-0600-3, 17856-0600-7, 17856-0600-9, 17856-0600-8, 17856-0600-04
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-05-27 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0600-1 | Gabapentin | 72 in 1 BOX | SOLUTION | 72 | 7 | |
| 17856-0600-2 | Gabapentin | 72 in 1 BOX | SOLUTION | 72 | 7 | |
| 17856-0600-3 | Gabapentin | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | 7 | |
| 17856-0600-4 | Gabapentin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 7 | |
| 17856-0600-5 | Gabapentin | 6 mL in 1 CUP, UNIT-DOSE | SOLUTION | 6 | 7 | |
| 17856-0600-6 | Gabapentin | 2 mL in 1 SYRINGE | SOLUTION | 2 | 7 | |
| 17856-0600-7 | Gabapentin | 5 in 1 SYRINGE | SOLUTION | 5 | 7 | |
| 17856-0600-8 | Gabapentin | 60 in 1 BOX, UNIT-DOSE | SOLUTION | 60 | 7 | |
| 17856-0600-9 | Gabapentin | 2 mL in 1 SYRINGE | SOLUTION | 2 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0600 | GABAPENTIN SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 7 | Current NDC, Legacy NDC, 9 package rows | 20250529_5969f1a8-d6d5-4967-add5-4e2492354d7b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0600-1 | ML - Milliliter | 17856-0600 | 247f9fe7-7bc3-4c3a-af79-da6efd4fc39b | 1 | 2025-06-13 |
| 17856-0600-2 | ML - Milliliter | 17856-0600 | 1da3e4a4-4f69-4ef7-bf22-970e207c9796 | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 36f74fdf-0dae-47a0-a7ea-e64ac91cd88f | 2026-09-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 429a1bb5-babf-4f36-8264-46d71164f1c0 | 2026-09-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | fbeccab7-08aa-4da3-868f-b47a1f3d41ef | 2026-09-14 | Warnings, Adverse reactions | 6CW7F3G59X |
| FlyLeaf RINGWORM TREATMENT | MICONAZOLE NITRATE 2% | Guangzhou Huixue Biotechnology Co., Ltd. | 5b597a3b-b5ff-2246-e063-6394a90a1046 | 2026-09-13 | Warnings | 059QF0KO0R |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 1ec2e07e-5a8e-41e5-9ece-485431c7c4ee | 2026-09-11 | Warnings, Adverse reactions | 283523 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4a975ebe-ae0a-446a-8a3d-2ca325e28f93 | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Advanced Rx of Tennessee, LLC | 5b3ba5e9-6e96-dea6-e063-6394a90aa2bb | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 934244c6-243d-436e-ad6c-f7bd28e45a86 | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Clear Eyes Maximum Itchy Eye Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE AND ZINC SULFATE | Prestige Brands Holdings, Inc. | 326a1462-78d1-42d6-8257-7e4f00d1f215 | 2026-09-10 | Warnings | PDC6A3C0OX |
| Clear Eyes Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | a26ef66e-2def-4c98-9959-d40d4cfe3108 | 2026-09-10 | Warnings | PDC6A3C0OX |
| Gabapentin | GABAPENTIN | Clinical Solutions Wholesale, LLC | b7f9a106-52c6-49e4-acf5-8fb07761ba4f | 2026-09-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Leader Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Cardinal Health | aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a | 2026-09-09 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | PDC6A3C0OX |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | d35cd5ac-5ed6-2405-e053-2995a90a6946 | 2026-09-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | PHOENIX RX LLC | 5a85ea98-4211-54eb-e063-6294a90aff33 | 2026-09-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 0ad67a07-59d0-4aaa-906b-befbbad8af31 | 2026-09-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | 1373587e-807a-462a-bff6-8a7113ce9f0a | 2026-09-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | American Health Packaging | 765c7ce0-bbf5-4265-8ff0-1ba092c69865 | 2026-08-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 78445dbf-c7cd-419f-a7be-72821e496628 | 2026-08-28 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.